Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024
Compare Profit and Loss Results of Godavari Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
43.00
70.00
162.79%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
113.00
43.00
70.00
162.79%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
3.00
-6.00
-200.00%
Raw Materials Consumed
85.00
2.00
83.00
4,150.00%
Power & Fuel Cost
6.00
18.00
-12.00
-66.67%
Employee Cost
5.00
16.00
-11.00
-68.75%
Operating Expenses
3.00
12.00
-9.00
-75.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
101.00
58.00
43.00
74.14%
Operating Profit (PBDIT) excl Other Income
11.00
-15.00
26.00
173.33%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
12.00
-14.00
26.00
185.71%
Interest
4.00
5.00
-1.00
-20.00%
Profit before Depriciation and Tax
8.00
-20.00
28.00
140.00%
Depreciation
2.00
6.00
-4.00
-66.67%
Profit Before Taxation & Exceptional Items
5.00
-26.00
31.00
119.23%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
-26.00
31.00
119.23%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
4.00
-26.00
30.00
115.38%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
-270.00
290.00
107.41%
Profit Available for appropriations
24.00
-297.00
321.00
108.08%
Appropriations
24.00
-297.00
321.00
108.08%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.82
-12.49
18.31
146.60%
Profit And Loss - Net Sales
Net Sales 113.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024
Profit And Loss - Interest
Interest 4.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.38 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024
